Kyorin to Announce MIC-'09 Mid-Term Business Plans
May 12, 2005
Kyorin Pharmaceutical Co., Ltd. (President: Ikuo Ogihara) announced the launch of Kyorin MIC-'09 Mid-Term Business Plans.
The pharmaceutical industry has recently been faced with ever-rising R&D costs due to the increased global competition in a new epock-making drug creation, while a negative impact has been posed by an unprecedented reduction in healthcare and drug expenditures politically implemented in developed countries, including Japan. Domestic drug manufacturers are compelled to meet the requirements of increased competitiveness caused by expanded market share of multi-national gigantic pharmaceutical companies as well as the ongoing M&A wave within the industry.
Adobe Reader software is required to view and print PDF files. The latest version of Adobe Reader can be downloaded by accessing the Adobe Systems Incorporated website.